According to the official website of the Tianjin Medical Purchasing Center, the price of Molnupiravir, a COVID-19 drug developed by US pharmaceutical company Merck, was 1,500 yuan ($222) per bottle of 40 capsules.
Albert Bourla, the CEO of US pharmaceutical giant Pfizer, said that the company is working with Chinese partners to provide Paxlovid, a COVID-19 pill developed by the firm, to China from the first half of this year.
Talks between Chinese regulators and US pharmaceutical company Pfizer regarding the potential inclusion of Paxlovid, an orally administered COVID-19 medication, in the country's public health insurance scheme have broken down.
